110 Views
Monday Poster Session
Category: Esophagus
Jennifer Kolb, MD, MS
University of California Irvine
Orange, CA, United States
Provider Attitudes | GI (N = 115) | PCP (N = 179) |
BE screening with upper endoscopy is effective for early esophageal cancer detection Strongly agree/agree, n (%) Neither agree nor disagree, n (%) Strongly disagree/disagree, n (%) | 83 (72.27) 20 (17.39) 12 (10.44) | 127 (70.95) 46 (25.70) 6 (3.35) |
BE screening with upper endoscopy reduces all-cause mortality Strongly agree/agree, n (%) Neither agree nor disagree, n (%) Strongly disagree/disagree, n (%) | 26 (22.61) 36 (31.30) 53 (46.09) | 39 (21.91) 109 (60.67) 31 (17.42) |
BE screening with upper endoscopy is cost-effective for at-risk individuals Strongly agree/agree, n (%) Neither agree nor disagree, n (%) Strongly disagree/disagree, n (%) | 64 (55.65) 34 (29.57) 17 (14.78) | 68 (37.99) 92 (51.40) 19 (10.62) |
Not performing Barrett’s esophagus screening poses malpractice liability Strongly agree/agree, n (%) Neither agree nor disagree, n (%) Strongly disagree/disagree, n (%) | 47 (40.87) 45 (39.13) 23 (20.00) | 46 (25.70) 103 (57.54) 30 (16.76) |
Primary care providers should not order BE screening based on lack of recommendation from the U.S. Preventative Services Task Force Strongly agree/agree, n (%) Neither agree nor disagree, n (%) Strongly disagree/disagree, n (%) | 20 (17.39) 44 (38.26) 51 (44.34) | 51 (28.49) 92 (51.40) 36 (20.12) |
Better data on the benefits of BE screening are needed Strongly agree/agree, n (%) Neither agree nor disagree, n (%) Strongly disagree/disagree, n (%) | 86 (74.78) 14 (12.17) 15 (13.04) | 117 (65.73) 56 (31.46) 5 (2.81) |
Better data on the harms of BE screening are needed Strongly agree/agree, n (%) Neither agree nor disagree, n (%) Strongly disagree/disagree, n (%) | 77 (66.95) 20 (17.39) 18 (15.75) | 105 (58.99) 66 (37.08) 7 (3.93) |
A randomized trial on BE screening would impact my decision to refer patients for screening Strongly agree/agree, n (%) Neither agree nor disagree, n (%) Strongly disagree/disagree, n (%) | 104 (90.44) 6 (5.22) 5 (4.35) | 143 (80.33) 33 (18.54) 2 (1.12) |
BE screening with upper endoscopy has equally strong supporting data as colon cancer screening with colonoscopy Strongly agree/agree, n (%) Neither agree nor disagree, n (%) Strongly disagree/disagree, n (%) | 7 (6.09) 24 (20.87) 84 (73.04) | 8 (4.57) 77 (43.26) 93 (52.25) |
Provider Barrier | GI | PCP |
I have difficulty knowing who should be ordered an upper endoscopy for Barrett’s esophagus screening Strongly agree/agree, n (%) Neither agree nor disagree, n (%) Strongly disagree/disagree, n (%) | 19 (15.83) 19 (15.83) 82 (68.34) | 113 (58.25) 45 (23.20) 36 (18.56) |
There are no effective treatments available for Barrett’s esophagus or esophageal cancer, even if found at an early stage through screening Strongly agree/agree, n (%) Neither agree nor disagree, n (%) Strongly disagree/disagree, n (%) | 2 (1.67) 0 (0) 118 (98.34) | 7 (3.61) 30 (15.46) 157 (80.93) |
I know the current guideline recommendations related to screening Barrett’s esophagus Strongly agree/agree, n (%) Neither agree nor disagree, n (%) Strongly disagree/disagree, n (%) | 91 (75.84) 21 (17.50) 8 (6.67) | 30 (15.47) 60 (30.93) 104 (53.61) |
Screening for Barrett’s esophagus is not my responsibility Strongly agree/agree, n (%) Neither agree nor disagree, n (%) Strongly disagree/disagree, n (%) | 2 (1.67) 11 (9.17) 107 (89.16) | 10 (5.21) 26 (13.54) 156 (81.25) |
Competing patient clinical issues prevent me from addressing screening for Barrett's esophagus Strongly agree/agree, n (%) Neither agree nor disagree, n (%) Strongly disagree/disagree, n (%) | 15 (12.50) 31 (25.83) 74 (61.67) | 85 (44.27) 53 (27.60) 54 (28.13) |
I do not have enough time in clinic to discuss Barrett's esophagus screening with patients Strongly agree/agree, n (%) Neither agree nor disagree, n (%) Strongly disagree/disagree, n (%) | 9 (7.50) 20 (16.67) 90 (75.83) | 63 (32.81) 57 (29.69) 72 (37.50) |
I am unsure if upper endoscopy as screening for Barrett's esophagus would be covered by insurance Strongly agree/agree, n (%) Neither agree nor disagree, n (%) Strongly disagree/disagree, n (%) | 25 (20.83) 26 (21.67) 69 (57.50) | 77 (40.11) 48 (25.00) 67 (34.90) |
Patients do not want to discuss Barrett’s esophagus screening Strongly agree/agree, n (%) Neither agree nor disagree, n (%) Strongly disagree/disagree, n (%) | 3 (2.50) 22 (18.33) 95 (79.16) | 10 (5.21) 63 (32.81) 119 (61.98) |
Patients have difficulty understanding information I present about Barrett’s esophagus screening Strongly agree/agree, n (%) Neither agree nor disagree, n (%) Strongly disagree/disagree, n (%) | 15 (12.50) 29 (24.17) 76 (63.33) | 30 (15.62) 76 (39.58) 86 (44.79) |
Patients who have been ordered an upper endoscopy for Barrett’s esophagus screening do not complete the endoscopy Strongly agree/agree, n (%) Neither agree nor disagree, n (%) Strongly disagree/disagree, n (%) | 5 (4.17) 33 (27.50) 82 (68.83) | 12 (6.25) 75 (39.06) 105 (54.68) |